Biotech's Finest Hour: Progress Update on BIO Policy Work and COVID-19

Join us for a fireside chat with BIO’s Leadership, Chairman Jeremy Levin, MB, BChir, DPhil, President, Chairman of the Board of Directors and Chief Executive Officer, Ovid Therapeutics and BIO CEO Michelle McMurry-Heath, MD, PhD. This interactive discussion will be moderated by Steve Clemons, Editor at Large from The Hill. Attendees will hear updates on BIO’s policy priorities and how the biotech sector is rising to meet the greatest public health challenge in a century, COVID-19.